Delivery Order SPE2DR25D2206-SPE2DR26F9EX7
- Not listed
- The Defense Logistics Agency awarded a $1,702.92 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for OPZELURA 1.5% Cream in 60-gram quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, with a ceiling value of $20,404.44. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.72 for OPZELURA 1.5% Cream 60GM on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery under the company's larger contracting...
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60 grams) valued at $1,493.37 with an ultimate completion date of October 30, 2025. This is a firm fixed price, non-set-aside contract executed on October 29, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters location. The award represents a single delivery order under AmerisourceBergen's larger federal contracting relationships supporting...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of OPZELURA 1.5% Cream in 60-gram units with a ceiling value of $33.5K. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside, competitively awarded contract. The award was issued on September 27, 2025, with performance of work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in a 60-gram unit on September 4, 2025, with a ceiling value of $2,171.95. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $43,268.98 to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60 grams) on November 20, 2025, with completion expected by November 21, 2025. This firm fixed-price, non-set-aside contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,650.79 on September 15, 2025, for OPZELURA 1.5% Cream in 60-gram quantities, with final delivery scheduled by September 16, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EX7Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,234.19 for OPZELURA 1.5% Cream in a 60-gram quantity on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal military healthcare procurement through the DLA's Medical Supply Chain. The company leverages its comprehensive IDC vehicle to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains for military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities. The award underscores AmerisourceBergen's demonstrated capability to compete successfully in open federal procurement and maintain reliable supply chains for specialized pharmaceutical products essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.2k | 12/7/25 |